FRANK GALANTE: Open Payments
NPI 1144530882 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 8 payments from 5 companies in 2025. Trend: 2023 $1,099 · 2024 $1,610 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $253 |
| Alkermes, Inc. | 2 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $208 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: AUSTEDO XR, LYBALVI, CAPLYTA, COBENFY, Qelbree.
Industry payments across NY — which companies pay providers there.
